# reload+after+2024-01-20 00:46:39.980566
address1§Building No. 5
address2§MATAM Advanced Technology Park
city§Haifa
zip§3508409
country§Israel
phone§972 74 710 8600
website§https://www.pluri-biotech.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Pluri Inc., a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production. The company's development pipeline includes PLX-PAD, is composed of maternal mesenchymal stromal cells originating from the placenta that is currently under phase III study for orthopedic, phase II study for COVID-19, and phase I/II clinical study for Steroid-Refractory cGVHD indications; and PLX-R18, is composed of fetal MSC like cells originating from the placenta that is currently under phase I study for HCT and pilot study for ARS indications. It is also involved in the development of modified PLX cells. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.
fullTimeEmployees§123
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Yaacov  Yanay', 'age': 52, 'title': 'President, CEO & Director', 'yearBorn': 1971, 'fiscalYear': 2023, 'totalPay': 575931, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Chen  Franco-Yehuda', 'age': 40, 'title': 'CFO, Treasurer & Secretary', 'yearBorn': 1983, 'fiscalYear': 2023, 'totalPay': 375239, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Lior  Raviv', 'title': 'Chief Technology Officer', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Efrat  Livne-Hadass', 'title': 'Vice President of Human Resources', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Nitsan  Halevy M.D.', 'title': 'Chief Medical Officer', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Nimrod  Bar Zvi', 'title': 'Chief Commercial Officer', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1703980800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.534
priceToSalesTrailing12Months§100.10773
currency§USD
dateShortInterest§1702598400
forwardEps§-1.2
exchange§NCM
quoteType§EQUITY
shortName§Pluri Inc.
longName§Pluri Inc.
firstTradeDateEpochUtc§1056979800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§dc99a21d-936b-37bb-af03-47baa5cbcabf
gmtOffSetMilliseconds§-18000000
recommendationMean§2.0
recommendationKey§buy
quickRatio§7.776
grossMargins§0.96457
ebitdaMargins§0.0
trailingPegRatio§None
